Sub-specialties: Haematopoietic Stem Cell ＆ Cellular Therapy
Conditions Treated by this Doctor:
Acute Lymphocytic Leukemia (ALL), Acute Lymphocytic Leukemia (ALL), Aplastic Anaemia, Chronic lymphocytic leukemia, Chronic lymphocytic leukemia, Chronic lymphocytic leukemia, Deep Vein Thrombosis, Deep Vein Thrombosis, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis.
Professor William Hwang is a highly respected clinician leader with a strong leadership and professional track record. He currently serves as Chief Executive Officer of the National Cancer Centre of Singapore, Chair of the Oncology Academic Clinical Programme (ACP) of Duke-NUS Medical School, Head of the SingHealth Duke-NUS Cell Therapy Centre (SDCT) and Senior Consultant of the Department of Haematology, Singapore General Hospital. He has previously provided stewardship for his multiple leadership portfolios, including Director, SingHealth Transplant; Head, SingHealth Duke-NUS Blood Cancer Centre; Head, Department of Haematology, Singapore General Hospital and Medical Director, Singapore Cord Blood Bank (SCBB).
Widely recognised for his expertise in haematological malignancies, Professor Hwang has previously served as Head for the Department of Haematology in the Singapore General Hospital (SGH), and Head for the SingHealth Duke-NUS Blood Cancer Centre. He was formerly President of the World Marrow Donor Association, President of the Singapore Society of Haematology, Chairman for the Chapter of Haematologists for the Academy of Medicine Singapore and Advisory Committee Member for the Center for International Blood & Marrow Transplant Research (CIBMTR. His clinical and research focus is primarily on blood and marrow transplants and he has previously led the Blood and Marrow Transplant Program in Singapore General Hospital, and also served as Medical Director of the Singapore Cord Blood Bank.
He is currently Executive Board Member of the Asia Pacific Blood and Marrow Transplantation Group (APBMT), Board Organising Committee (BOC) member of the Singapore Translational Cancer Consortium, BOC member of the Advanced Cell Therapy Research Institute of Singapore (ACTRIS) and Board member of the Lien Centre for Palliative Care (LCPC), as well as Committee Member of the Women’s Health Committee of the Ministry of Health (MOH), Co-Chair of the MOH Cell, Tissue and Gene Therapy (CTGT) Workgroup, Co-Chair of the MOH Tissue Banking Working Committee and Co-Chair of the National Advisory Committee on Cancer (NACC).
Professor Hwang is also a faculty member of the Cancer and Stem Cell Biology Programme in Duke-NUS as well as Clinical Lecturer at the Yong Loo Lin Medical School. He has published over a hundred clinical and scientific papers in the field of haematology and oncology as well as two books and several book chapters.
In his role as Chief Executive Officer of the National Cancer Centre Singapore (NCCS), Professor Hwang plans to help further advance the NCCS into a global leading cancer centre, by improving patient care through the best talents and best research.
H-Index: 26 (Google Scholar Citation) (as at 10 Sep 2020)
PubMed Link: https://www.ncbi.nlm.nih.gov/myncbi/1dgCwdr-kYFAu/bibliography/public/
Patents (related or unrelated to the study):